{
  "name": "ADC Therapeutics SA",
  "legal_name": "ADC Therapeutics SA",
  "ticker": "ADCT",
  "tickers": [
    "ADCT"
  ],
  "cik": "0001771910",
  "page_url": "https://steadybase.io/company/adc-therapeutics-sa/",
  "markdown_url": "https://steadybase.io/company/adc-therapeutics-sa.md",
  "json_url": "https://steadybase.io/company/adc-therapeutics-sa.json",
  "as_of": "2026-11-21",
  "last_filed": "2026-11-10",
  "industry": {
    "sic": "2834",
    "description": "Pharmaceutical Preparations"
  },
  "headquarters": {
    "city": "Epalinges",
    "state": "V8",
    "country": "US"
  },
  "exchanges": [
    "NYSE"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "Non-accelerated filer<br>Smaller reporting company",
  "state_of_incorporation": "V8",
  "website": "adctherapeutics.com",
  "investor_relations_url": null,
  "linkedin_company_url": "https://www.linkedin.com/company/adc-therapeutics",
  "summary": {
    "text": "ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (“ADCs”), transforming treatment for patients through our focused portfolio with ZYNLONTA (loncastuximab tesirine-lpyl), a CD19-directed ADC.S. Food and Drug Administration (“FDA”) and conditional approval from the European Commission, China National Medical Products Administration (“NMPA”) and Health Canada for the treatment of relapsed or refractory DLBCL after two or more lines of systemic therapy.",
    "section": "Item 1. Business",
    "period_end": "2025-12-31",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
  },
  "key_facts": [
    {
      "key": "revenue",
      "label": "Revenue",
      "value": 81357000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html",
      "text": "Revenue: $81.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026)."
    },
    {
      "key": "operating_income",
      "label": "Operating income",
      "value": -121499000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html",
      "text": "Operating income: -$121.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026)."
    },
    {
      "key": "net_income",
      "label": "Net income",
      "value": -142623000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html",
      "text": "Net income: -$142.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026)."
    },
    {
      "key": "sga",
      "label": "SG&A",
      "value": 79933000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "derived",
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html",
      "text": "SG&A: $79.9M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026)."
    },
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 127667695,
      "unit": "shares",
      "period_end": "2026-08-03",
      "form": "10-Q",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026056711/0001628280-26-056711-index.html",
      "text": "Shares outstanding: 127,667,695 as of Aug 3, 2026 (10-Q filed Aug 13, 2026)."
    },
    {
      "key": "auditor",
      "label": "Auditor",
      "value": "Pricewaterhousecoopers Sa",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm",
      "text": "Auditor: Pricewaterhousecoopers Sa, Lausanne, Switzerland, named in the latest 10-K."
    }
  ],
  "metrics": {
    "revenue": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 81357000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 70837000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 69558000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-03-27",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/0001628280-25-015131-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 209908000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-03-13",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828024010843/0001628280-24-010843-index.html"
      }
    ],
    "operating_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -121499000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -130654000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": -165986000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-03-27",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/0001628280-25-015131-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": -123344000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-03-13",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828024010843/0001628280-24-010843-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": -261720000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "20-F",
        "filed": "2023-03-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828023008056/0001628280-23-008056-index.html"
      }
    ],
    "net_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -142623000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -157846000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": -240053000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-03-27",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/0001628280-25-015131-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": -157128000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-03-13",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828024010843/0001628280-24-010843-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": -230026000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "20-F",
        "filed": "2023-03-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828023008056/0001628280-23-008056-index.html"
      }
    ],
    "sga": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 79933000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 85909000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-10",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/0001628280-26-016491-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 105888000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2025-03-27",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/0001628280-25-015131-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 143494000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2024-03-13",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828024010843/0001628280-24-010843-index.html"
      }
    ]
  },
  "next_earnings": {
    "date": "2027-01-04",
    "confidence": "low",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Ameet Mallik",
      "title": "Chief Executive Officer of ADC Therapeutics",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/ameet-mallik-1002293",
      "form": "8-K",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326016945/dp256258_ex9901.htm"
    },
    {
      "name": "Jose Carmona",
      "title": "Chief Financial Officer",
      "role": "officer",
      "linkedin_url": "https://www.linkedin.com/in/jose-ignacio-carmona-636462",
      "form": "4",
      "filed": "2026-07-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026047033/0001628280-26-047033-index.htm"
    },
    {
      "name": "Mohamed Zaki",
      "title": "MD, PhD, Chief Medical Officer of ADC Therapeutics",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/mohamed-zaki-59aa815",
      "form": "8-K",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326016945/dp256258_ex9901.htm"
    },
    {
      "name": "Peter J. Graham",
      "title": "Chief Legal Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/peter-graham-89827474",
      "form": "4",
      "filed": "2026-07-02",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026047034/0001628280-26-047034-index.htm"
    },
    {
      "name": "Lisa Kallebo",
      "title": "Corporate Controller and Chief Accounting Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Lisa Michelle Kallebo",
      "title": "Chief Accounting Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-02-18",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026009283/0001628280-26-009283-index.htm"
    },
    {
      "name": "Ron Squarer",
      "title": "Chairman of the Board of Directors",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Jean-Pierre Bizzari",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Peter Hug",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Robert Azelby",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Timothy Coughlin",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Tyrell Rivers",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Victor Sandor",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Viviane Monges",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "name": "Jean-Pierre Bizzari, M.D.",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    },
    {
      "name": "Jose “Pepe” Carmona",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": "https://www.linkedin.com/in/jose-ignacio-carmona-636462",
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    },
    {
      "name": "Mohamed Zaki, M.D., Ph.D.",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    },
    {
      "name": "Peter Graham",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    },
    {
      "name": "Timothy Coughlin, CPA",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-11-09",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026071899/adc-20261109.htm"
    },
    {
      "filed": "2026-11-04",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326016945/dp256258_8k.htm"
    },
    {
      "filed": "2026-10-13",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "3.02",
          "label": "Unregistered sales of equity securities",
          "signal": "financing"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326015465/dp254756_8k.htm"
    },
    {
      "filed": "2026-08-13",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326012287/dp251718_8k.htm"
    },
    {
      "filed": "2026-07-02",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/dp249055_8k.htm"
    },
    {
      "filed": "2026-06-24",
      "items": [
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326009416/dp248849_8k.htm"
    },
    {
      "filed": "2026-06-03",
      "items": [
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326008465/dp247928_8k.htm"
    },
    {
      "filed": "2026-06-02",
      "items": [
        {
          "item": "5.07",
          "label": "Submission of matters to a vote of security holders",
          "signal": "governance"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326008321/dp247757_8k.htm"
    },
    {
      "filed": "2026-05-04",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026029524/adc-20260504.htm"
    },
    {
      "filed": "2026-03-10",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016238/adc-20260310.htm"
    }
  ],
  "insider_trades": [],
  "quotes": [
    {
      "text": "During the third quarter, we made meaningful progress toward strengthening ADC Therapeutics' balance sheet and increasing strategic optionality while advancing clinical opportunities for ZYNLONTA®",
      "speaker": "Ameet Mallik",
      "title": "Chief Executive Officer of ADC Therapeutics",
      "form": "8-K",
      "filed": "2026-11-09",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026071899/adct-20260930pressrelease.htm"
    },
    {
      "text": "We are pleased by the breadth of the ZYNLONTA clinical program and the growing body of evidence showcased through multiple presentations at ASH",
      "speaker": "Mohamed Zaki",
      "title": "MD, PhD, Chief Medical Officer of ADC Therapeutics",
      "form": "8-K",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326016945/dp256258_ex9901.htm"
    },
    {
      "text": "We believe the emerging data from LOTIS-7 and MZL reinforce the best-in-class potential of ZYNLONTA in these settings and support our pursuit of an expanded role in treating these B-cell malignancies through potential compendia and regulatory pathways",
      "speaker": "Ameet Mallik",
      "title": "Chief Executive Officer of ADC Therapeutics",
      "form": "8-K",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326016945/dp256258_ex9901.htm"
    }
  ],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-10-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000095010326015465/dp254756_8k.htm"
    },
    {
      "form": "10-K",
      "filed": "2026-03-10",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828026056711/adc-20260630.htm"
    },
    {
      "form": "20f",
      "filed": "2023-03-15",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000162828023008056/adc-20221231.htm"
    },
    {
      "form": "DEF 14A",
      "filed": "2026-04-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}